Decoy Therapeutics Inc. Stock Analysis & AI Score
Decoy Therapeutics Inc. (DCOY) has an ST Score of 34.5 (C-), driven by its Growth (B) and held back by its Profitability (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Decoy Therapeutics Inc. (DCOY) has an ST Score of 34.5 (C-), driven by its Growth (B) and held back by its Profitability (F). Analysts rate it Buy.
- Strongest
- GrowthB
- Weakest
- ProfitabilityF
All factor grades
- GrowthB
- ValuationB-
- Financial StrengthC
- MomentumC-
- ProfitabilityF
- Piotroski2/9
Contact
DCOY stock: frequently asked questions
What is DCOY's ST Score?
Decoy Therapeutics Inc. (DCOY) has an ST Score of 34.5 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is DCOY a buy, hold, or sell?
Analysts rate DCOY a Buy. Our ST Score grades it C- (34.5/100). The ST Score is a data-driven signal, not a recommendation.
What are DCOY's factor grades?
Valuation B-, Profitability F, Financial Strength C, Momentum C-, Growth B.
What is DCOY's valuation grade?
Decoy Therapeutics Inc. (DCOY) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is DCOY's growth grade?
Decoy Therapeutics Inc. (DCOY) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is DCOY's profitability grade?
Decoy Therapeutics Inc. (DCOY) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is DCOY's financial strength grade?
Decoy Therapeutics Inc. (DCOY) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is DCOY's Piotroski score?
Decoy Therapeutics Inc. (DCOY) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.